Skip to content

Pulsar-18 6/100/135Recalls & reported problems

Biotronik AG · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07640130436640), received between Jul 12, 2022 and Jul 12, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Difficult or Delayed Positioning” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Difficult or Delayed Positioning1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 12, 2022Difficult or Delayed Positioning; Difficult or Delayed Positioning

    THE PULSAR-18 STENT SYSTEM WAS CHOSEN FOR THE TREATMENT BUT IT WAS NOT POSSIBLE TO RELEASE THE STENT WITHIN THE LESION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14986748 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page